Vitamin B6 catabolism and psoriasis risk: a cross-sectional study
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llaf065 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Ruimin Bai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Psoriasis, Pyridoxal Phosphate, Pyridoxic Acid, Vitamin B 6. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: major research plan.
Abstract (Originalsprache)
Background
Psoriasis is a common autoimmune inflammatory disease. Vitamin B6 is crucial for the body’s inflammatory response, yet the relationship between 4-pyridoxic acid (4-PA), pyridoxal 5′-phosphate (PLP) and vitamin B6 turnover (4-PA/PLP) in psoriasis remains unexplored.
Objectives
To investigate the relationship of 4-PA, PLP and vitamin B6 catabolism with the risk of psoriasis.
Methods
This cross-sectional study analysed records for 7540 participants from the US National Health and Nutrition Examination Survey. Vitamin B6 catabolism was assessed via the serum 4-PA to PLP ratio (4-PA/PLP). The primary outcome was psoriasis, evaluated using weighted univariate and multivariate logistic regression to determine odds ratios (OR) and 95% confidence intervals (CI). Subgroup analyses were performed by age, gender, body mass index (BMI), hypertension, dyslipidaemia and cardiovascular disease.
Results
Of the participants, 208 had psoriasis. After adjusting for confounders, 4-PA levels in the ‘cutoff above’ group were positively associated with psoriasis (OR 1.51, 95% CI 1.03–2.20). Additionally, 4-PA/PLP correlated with an increased psoriasis risk (OR 1.82, 95% CI 1.02–3.26). However, PLP levels did not show a significant association. The positive link between 4-PA/PLP and psoriasis was consistent in individuals with BMI ≥ 25 kg m–² and hypertension, and in those without dyslipidaemia.
Conclusions
The results revealed a significant association between 4-PA and 4-PA/PLP levels in the presence of psoriasis. However, further extensive prospective studies are necessary to establish causality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, China.
Förderung
- major research plan
Zitieren
APA
Bai, R., Cheng, X., Yang, Y., Zhang, J., & Tian, Q. (2025). Vitamin B6 catabolism and psoriasis risk: a cross-sectional study. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf065
Vancouver
Bai R, Cheng X, Yang Y, Zhang J, Tian Q. Vitamin B6 catabolism and psoriasis risk: a cross-sectional study. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf065
BibTeX
@article{Bai2025,
author = {Bai, Ruimin and Cheng, Xiaoqing and Yang, Yajie and Zhang, Jian and Tian, Qiong},
title = {Vitamin B6 catabolism and psoriasis risk: a cross-sectional study},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llaf065}
}
EUVIMED